Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
出版年份 2020 全文链接
标题
Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
作者
关键词
-
出版物
Cancers
Volume 12, Issue 4, Pages 926
出版商
MDPI AG
发表日期
2020-04-10
DOI
10.3390/cancers12040926
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Elimination of hepatitis C in Europe: can WHO targets be achieved?
- (2020) M. Matičič et al. CLINICAL MICROBIOLOGY AND INFECTION
- Molecular therapies for HCC: Looking outside the box
- (2020) Sandrine Faivre et al. JOURNAL OF HEPATOLOGY
- Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy
- (2019) Jianguang Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
- (2019) Lin Xiao et al. MOLECULAR THERAPY
- Immune landscape of hepatocellular carcinoma microenvironment: Implications for prognosis and therapeutic applications
- (2019) Elisabetta Cariani et al. LIVER INTERNATIONAL
- The Natural Cytotoxicity Receptors in Health and Disease
- (2019) Alexander David Barrow et al. Frontiers in Immunology
- Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function
- (2019) Julián Piñeiro Fernández et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structure-based rational design of a novel chimeric PD1-NKG2D receptor for natural killer cells
- (2019) Changjiang Guo et al. MOLECULAR IMMUNOLOGY
- Impairment of NKG2D-Mediated Tumor Immunity by TGF-β
- (2019) Mariya Lazarova et al. Frontiers in Immunology
- Epidermal Growth Factor Receptor Family and its Role in Gastric Cancer
- (2019) Chiara Arienti et al. Frontiers in Oncology
- Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells
- (2018) Jun Arai et al. INTERNATIONAL JOURNAL OF CANCER
- Predominance of regorafenib over sorafenib: Restoration of membrane-bound MICA in hepatocellular carcinoma cells
- (2018) Jun Arai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The HCMV protein UL148A Downregulates the Activating NK Cell Ligand MICA to Avoid NK Cell Attack
- (2018) Liat Dassa et al. JOURNAL OF VIROLOGY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
- (2018) Lucas Ferrari de Andrade et al. SCIENCE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Clinical and Biologic Correlates of Neurotoxicity Associated with CAR T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia (B-ALL)
- (2018) Bianca D. Santomasso et al. Cancer Discovery
- Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10
- (2018) Kaku Goto et al. Oncotarget
- A CS1-NKG2D Bispecific Antibody Collectively Activates Cytolytic Immune Cells against Multiple Myeloma
- (2018) Wing Keung Chan et al. Cancer Immunology Research
- The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity
- (2018) Marina Babic et al. Frontiers in Immunology
- Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
- (2018) Rohtesh S. Mehta et al. Frontiers in Immunology
- IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction
- (2018) Nicholas J. W. Easom et al. Frontiers in Immunology
- Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma
- (2018) Stefania Mantovani et al. HEPATOLOGY
- Chimeric Antigen Receptor T Cells: Extending Translation from Liquid to Solid Tumors
- (2018) Michael A. Morgan et al. HUMAN GENE THERAPY
- CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
- (2018) Hannah M. Knochelmann et al. Frontiers in Immunology
- Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion
- (2018) Linsen Ye et al. Journal for ImmunoTherapy of Cancer
- Dysregulated cellular functions and cell stress pathways provide critical cues for activating and targeting natural killer cells to transformed and infected cells
- (2017) David H. Raulet et al. IMMUNOLOGICAL REVIEWS
- Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity
- (2017) Barbara Oliviero et al. JOURNAL OF HEPATOLOGY
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
- (2017) Zachary B. Davis et al. SEMINARS IN IMMUNOLOGY
- FDA Approves Second CAR T-cell Therapy
- (2017) Cancer Discovery
- First-Ever CAR T-cell Therapy Approved in U.S.
- (2017) Cancer Discovery
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
- (2016) D. A. Vallera et al. CLINICAL CANCER RESEARCH
- Regulation of NKG2D Expression and Signaling by Endocytosis
- (2016) Rosa Molfetta et al. TRENDS IN IMMUNOLOGY
- HBV suppresses expression of MICA/B on hepatoma cells through up-regulation of transcription factors GATA2 and GATA3 to escape from NK cell surveillance
- (2016) Yun Guan et al. Oncotarget
- Targeting HER2 for the Treatment of Breast Cancer
- (2015) Mothaffar F. Rimawi et al. Annual Review of Medicine
- The IL-15-Based ALT-803 Complex Enhances Fc RIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas
- (2015) M. Rosario et al. CLINICAL CANCER RESEARCH
- Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
- (2015) Joon Hyeok Lee et al. GASTROENTEROLOGY
- Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model
- (2015) Dimitrios Mathios et al. INTERNATIONAL JOURNAL OF CANCER
- Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells
- (2015) Alessandra Zingoni et al. JOURNAL OF IMMUNOLOGY
- Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells
- (2015) Linda Quatrini et al. Science Signaling
- Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells
- (2015) Linda Quatrini et al. Science Signaling
- The Shared and Contrasting Roles of IL2 and IL15 in the Life and Death of Normal and Neoplastic Lymphocytes: Implications for Cancer Therapy
- (2015) T. A. Waldmann Cancer Immunology Research
- NKG2D Receptor and Its Ligands in Host Defense
- (2015) L. L. Lanier Cancer Immunology Research
- NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
- (2015) Wei Wang Frontiers in Immunology
- Effect of NKG2D ligand expression on host immune responses
- (2015) Marine Champsaur et al. IMMUNOLOGICAL REVIEWS
- UPR decreases CD226 ligand CD155 expression and sensitivity to NK cell-mediated cytotoxicity in hepatoma cells
- (2014) Jiuyu Gong et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Effect of tumor cells and tumor microenvironment on NK-cell function
- (2014) Massimo Vitale et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo
- (2014) Wen Jiang et al. IMMUNOBIOLOGY
- MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma
- (2014) Liang Fang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- TGF-β-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells
- (2014) Antonella Carambia et al. JOURNAL OF HEPATOLOGY
- Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression
- (2014) A. Clayton et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: The Metalloproteinase ADAM17/TNF- -Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein
- (2014) P. Boutet et al. JOURNAL OF IMMUNOLOGY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- IgG Subclasses and Allotypes: From Structure to Effector Functions
- (2014) Gestur Vidarsson et al. Frontiers in Immunology
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008
- (2013) Omodele Ashiru et al. BIOCHEMICAL JOURNAL
- A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells
- (2013) Y.-H. Chang et al. CANCER RESEARCH
- Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cells
- (2013) Jianmin Wu et al. CARCINOGENESIS
- Regulation of the expression of the liver cancer susceptibility gene MICA by microRNAs
- (2013) Takahiro Kishikawa et al. Scientific Reports
- New prospects on the NKG2D/NKG2DL system for oncology
- (2013) Evelyn Ullrich et al. OncoImmunology
- Adoptive Cellular Therapy using Cells Enriched for NKG2D+CD3+CD8+T Cells after Autologous Transplantation for Myeloma
- (2012) Kenneth R. Meehan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions
- (2012) J. L. Espinoza et al. HAEMATOLOGICA
- Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
- (2012) Vinod Kumar et al. PLoS One
- Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the c cytokines and TGF- 1
- (2011) Y. P. Park et al. BLOOD
- Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer
- (2011) Cédric Coulouarn et al. CARCINOGENESIS
- Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
- (2011) Valerie Chew et al. GUT
- Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence
- (2011) Hiroteru Kamimura et al. JOURNAL OF HEPATOLOGY
- Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes
- (2010) O. Ashiru et al. CANCER RESEARCH
- Hepatitis C Virus Infection Downregulates the Ligands of the Activating Receptor NKG2D
- (2010) Chaoyang Wen et al. Cellular & Molecular Immunology
- Anti-GD2 Antibody Therapy for GD2-Expressing Tumors
- (2010) F. Navid et al. CURRENT CANCER DRUG TARGETS
- A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells☆☆☆
- (2010) Jun Nakajima et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Growth Suppression of Human Hepatocellular Carcinoma Xenografts by a Monoclonal Antibody CH12 Directed to Epidermal Growth Factor Receptor Variant III
- (2010) Hua Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines
- (2010) Damien Sène et al. PLoS Pathogens
- Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
- (2009) Yu Abe et al. EXPERIMENTAL HEMATOLOGY
- Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9
- (2009) Keisuke Kohga et al. HEPATOLOGY
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- Chimeric NKG2D Expressing T Cells Eliminate Immunosuppression and Activate Immunity within the Ovarian Tumor Microenvironment
- (2009) A. Barber et al. JOURNAL OF IMMUNOLOGY
- High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor fusion protein, in metastatic melanoma and colorectal cancer
- (2009) A. Bessard et al. MOLECULAR CANCER THERAPEUTICS
- Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
- (2008) Kiyotaka Nakano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting EGFR in Colorectal Cancer
- (2008) Wells A. Messersmith et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started